Northeast Pharmaceutical announced that in order to regulate related transactions and ensure that the interests of the company and all shareholders are not harmed, the company has formulated a related transaction management system. Clarify that related parties include related legal entities and natural persons, and define the scope of related relationships and transactions. It is stipulated that transactions involving different amounts shall be reviewed and approved separately by the shareholders' meeting, the board of directors, and the general manager's office. Relevant directors and shareholders are required to avoid voting during review. At the same time, the disclosure standards and content of information on related transactions have been clarified, such as transactions with related natural persons exceeding 300,000 yuan, transactions with related legal entities exceeding 3 million yuan, and accounting for at least 0.5% of the absolute value of net assets, which must be promptly disclosed. The system takes effect after review and approval by the shareholders' meeting.

Zhitongcaijing · 2d ago
Northeast Pharmaceutical announced that in order to regulate related transactions and ensure that the interests of the company and all shareholders are not harmed, the company has formulated a related transaction management system. Clarify that related parties include related legal entities and natural persons, and define the scope of related relationships and transactions. It is stipulated that transactions involving different amounts shall be reviewed and approved separately by the shareholders' meeting, the board of directors, and the general manager's office. Relevant directors and shareholders are required to avoid voting during review. At the same time, the disclosure standards and content of information on related transactions have been clarified, such as transactions with related natural persons exceeding 300,000 yuan, transactions with related legal entities exceeding 3 million yuan, and accounting for at least 0.5% of the absolute value of net assets, which must be promptly disclosed. The system takes effect after review and approval by the shareholders' meeting.